| 0.041 Delayed Data As of Feb 26 |  0.0001 / +0.24%Today’s Change | 0.03 Today|||52-Week Range 0.06 | +18.16% Year-to-Date |
| Previous close | 0.04 |
| Today’s open | 0.04 |
| Day’s range | 0.04 - 0.04 |
| Volume | 48,949 |
| Average volume (3 months) | 96,200 |
| Market cap | $15.1M |
| Dividend yield | -- |
| Earnings growth (last year) | 0.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -10.14% |
| P/E ratio | NM |
| Price/Sales | 3.15 |
| Price/Book | 3.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| APPYVenaxis Inc | +0.04 | +8.65% |
| GBSNGreat Basin Scientif... | +0.12 | +4.70% |
| GALTUGalectin Therapeutic... | 0.00 | 0.00% |
| TROVUTrovagene Inc | 0.00 | 0.00% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $6.8M |
| Annual profit (last year) | -$2.5M |
| Net profit margin | -35.94% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Steve T. Laflin |
Chief Financial Officer & Secretary Laurie A. McKenzie-Carter |
Corporate headquarters Idaho Falls, Idaho |
